About Nectome
Nectome is a company based in San Francisco (United States) founded in 2015 by Robert McIntyre and Michael McCanna. Nectome operates in a competitive market with competitors including Brooks Automation, Hemanext, Bridge to Life, Cellbox Solutions and Atelerix, among others.
- Headquarter San Francisco, United States
- Founders Robert McIntyre, Michael McCanna
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Nectome
Investors in Nectome
Nectome has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Y Combinator.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage startups are accelerated via funding and educational programs.
|
Locked | Locked | Locked |
Investor details for Nectome
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Nectome
Investment portfolio details for Nectome
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Nectome
Detailed financials for Nectome
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nectome Comparisons
Peer comparison for Nectome
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Nectome
Nectome operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Brooks Automation, Hemanext, Bridge to Life, Cellbox Solutions and Atelerix, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Vacuum robots for semiconductor wafer handling are developed.
|
|
| Locked | Locked | Locked |
Technologies for blood and product storage are developed.
|
|
| Locked | Locked | Locked |
Cold storage solutions for organ transplant preservation are provided.
|
|
| Locked | Locked | Locked |
Portable devices for cell storage and transport are provided.
|
|
| Locked | Locked | Locked |
Technology for cell storage and transportation is developed.
|
|
| Locked | Locked | Locked |
Platform for cryostorage and long-term biological preservation is provided.
|
Detailed competitors of Nectome
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nectome
Complete news archive for Nectome
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nectome
Nectome was founded in 2015 and raised its 1st funding round 3 years after it was founded.
Nectome is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Robert McIntyre is the current CEO of Nectome. They have also founded this company.
The company was founded in 2015 in San Francisco, United States, focusing on biotechnology for brain preservation. Techniques employed include fixation with glutaraldehyde to stabilize synapses and halt decay, altering the brains watery state to a rubber-like consistency. This is followed by vitrification at -122C for extended storage. Such methods, established over decades for biological specimens like organs and animals, support long-term preservation services in the sector.
Nectome's top competitors include Brooks Automation, Hemanext and Bridge to Life.
Nectome has 1 investor. Key investors include Y Combinator.